The global Human Microbiome market size in 2023 is 198.3 million US dollars, and it is expected to be 1318.7 million US dollars by 2030, with a compound annual growth rate of 31.1% expected in 2024-2030.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Human Microbiome market include ENTEROME, Yakult, DuPont de Nemours Inc., ViThera Pharmaceuticals Inc., and Second Genome Inc.. The share of the top 3 players in the Human Microbiome market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Human Microbiome market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Probiotics accounted for XX% of Human Microbiome market in 2023. Prebiotics share of XX%.
Therapeutics accounted for XX% of the Human Microbiome market in 2023. Diagnostics accounts for XX%.

The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.

The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding Global Human Microbiome Market dynamics, structure by identifying and analyzing the market segments and project the global market size.

In addition, the market SWOT analysis, dynamics, trends, technologies, opportunities and challenges analysis are covered in the report.

Further, the report also focuses on the competitive analysis of key players by product, financial position, product portfolio, growth strategies, and regional presence.
 
Chapter Outline
Chapter 1: Introduces the product overview, market scope, product classification, and application division, and then includes research purposes, report timeline, and economic analysis of global regions.
Chapter 2: Analyzes the main companies in the Human Microbiome industry, including their main businesses, products/services, revenue, gross and gross margin.
Chapters 3-5: Segmented the global Human Microbiome market by type, application and region. Analyze the revenue and sales of market segments from different perspectives.
Chapters 6-11: Provide North America, EMEA, China, Asia-Pacific and Latin America Human Microbiome market type, application, country and player market segmentation revenue data.
Chapter 12: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry, and includes industry mergers & acquisitions and industry new entrants and expansion plans.
Chapter 13: The main points and conclusions of the report.

Highlights-Regions

North America
United States
Canada
China
Asia Pacific (Excluding China)
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Nordic
Latin America
Brazil
Argentina
Mexico
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Player list
ENTEROME
Yakult
DuPont de Nemours Inc.
ViThera Pharmaceuticals Inc.
Second Genome Inc.
Microbiome Therapeutics LLC
Vedanta Biosciences Inc.
Osel Inc.
Merck Sharp & Dohme Corp
Seres Therapeutics

Types list
Probiotics
Prebiotics
Medical Foods

Application list
Therapeutics
Diagnostics

Table of Content

1 Human Microbiome Market Introduction and Overview
1.1 Human Microbiome Definition
1.2 Market Size Analysis by Types
1.3 Market Size Analysis by Application
1.4 Research Purposes
1.5 Report Timeline
1.6 Economic Analysis of Global Regions
2 Players Profiles
2.1 ENTEROME
2.1.1 ENTEROME Company Profile
2.1.2 Human Microbiome Product Overview
2.1.3 ENTEROME Human Microbiome Market Performance (2019-2024)
2.1.4 ENTEROME Business Overview
2.2 Yakult
2.2.1 Yakult Company Profile
2.2.2 Human Microbiome Product Overview
2.2.3 Yakult Human Microbiome Market Performance (2019-2024)
2.2.4 Yakult Business Overview
2.3 DuPont de Nemours Inc.
2.3.1 DuPont de Nemours Inc. Company Profile
2.3.2 Human Microbiome Product Overview
2.3.3 DuPont de Nemours Inc. Human Microbiome Market Performance (2019-2024)
2.3.4 DuPont de Nemours Inc. Business Overview
2.4 ViThera Pharmaceuticals Inc.
2.4.1 ViThera Pharmaceuticals Inc. Company Profile
2.4.2 Human Microbiome Product Overview
2.4.3 ViThera Pharmaceuticals Inc. Human Microbiome Market Performance (2019-2024)
2.4.4 ViThera Pharmaceuticals Inc. Business Overview
2.5 Second Genome Inc.
2.5.1 Second Genome Inc. Company Profile
2.5.2 Human Microbiome Product Overview
2.5.3 Second Genome Inc. Human Microbiome Market Performance (2019-2024)
2.5.4 Second Genome Inc. Business Overview
2.6 Microbiome Therapeutics LLC
2.6.1 Microbiome Therapeutics LLC Company Profile
2.6.2 Human Microbiome Product Overview
2.6.3 Microbiome Therapeutics LLC Human Microbiome Market Performance (2019-2024)
2.6.4 Microbiome Therapeutics LLC Business Overview
2.7 Vedanta Biosciences Inc.
2.7.1 Vedanta Biosciences Inc. Company Profile
2.7.2 Human Microbiome Product Overview
2.7.3 Vedanta Biosciences Inc. Human Microbiome Market Performance (2019-2024)
2.7.4 Vedanta Biosciences Inc. Business Overview
2.8 Osel Inc.
2.8.1 Osel Inc. Company Profile
2.8.2 Human Microbiome Product Overview
2.8.3 Osel Inc. Human Microbiome Market Performance (2019-2024)
2.8.4 Osel Inc. Business Overview
2.9 Merck Sharp & Dohme Corp
2.9.1 Merck Sharp & Dohme Corp Company Profile
2.9.2 Human Microbiome Product Overview
2.9.3 Merck Sharp & Dohme Corp Human Microbiome Market Performance (2019-2024)
2.9.4 Merck Sharp & Dohme Corp Business Overview
2.10 Seres Therapeutics
2.10.1 Seres Therapeutics Company Profile
2.10.2 Human Microbiome Product Overview
2.10.3 Seres Therapeutics Human Microbiome Market Performance (2019-2024)
2.10.4 Seres Therapeutics Business Overview
3 Global Human Microbiome Historical and Forecast Market Analysis by Type
3.1 Global Human Microbiome Revenue and Market Share by Type
3.2 Global Human Microbiome Revenue Market Forecast by Type (2024-2030)
4 Global Human Microbiome Historical and Forecast Market Analysis by Application
4.1 Global Human Microbiome Revenue Market Share by Application (2019-2024)
4.2 Human Microbiome Revenue Market Forecast by Application (2024-2030)
5 Global Market Growth Trends Analysis
5.1 Global Human Microbiome Market Size & Forecast (2019-2030)
5.2 Human Microbiome Growth Trends Analysis by Regions
5.2.1 Human Microbiome Market Size by Regions: 2019 VS 2024 VS 2030
5.2.2 Human Microbiome Historic Market Size by Regions (2019-2024)
5.2.3 Human Microbiome Forecasted Market Size by Regions (2024-2030)
5.2.4 North America Human Microbiome Market Size & Forecast (2019-2030)
5.2.5 Europe Human Microbiome Market Size & Forecast (2019-2030)
5.2.6 China Human Microbiome Market Size & Forecast (2019-2030)
5.2.7 Asia-Pacific (Excluding China) Human Microbiome Market Size & Forecast (2019-2030)
5.2.8 Latin America Human Microbiome Market Size & Forecast (2019-2030)
5.2.9 Middle East & Africa Human Microbiome Market Size & Forecast (2019-2030)
6 North America
6.1 North America Human Microbiome Revenue by Players
6.2 North America Human Microbiome Revenue by Types
6.3 North America Human Microbiome Revenue by Applications
6.4 North America Human Microbiome Market by Countries
6.4.1 North America Human Microbiome Revenue by Countries (2019-2030)
6.5 United States
6.6 Canada
7 China
7.1 China Human Microbiome Revenue by Players
7.2 China Human Microbiome Revenue by Types
7.3 China Human Microbiome Revenue by Applications
7.4 China
8 Asia Pacific (Excluding China)
8.1 Asia Pacific Human Microbiome Revenue by Players
8.2 Asia Pacific Human Microbiome Revenue by Types
8.3 Asia Pacific Human Microbiome Revenue by Applications
8.4 Asia Pacific Human Microbiome Market by Countries
8.4.1 Asia Pacific Human Microbiome Revenue by Countries (2019-2030)
8.5 Japan
8.6 Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Europe
9.1 Europe Human Microbiome Revenue by Players
9.2 Europe Human Microbiome Revenue by Types
9.3 Europe Human Microbiome Revenue by Applications
9.4 Europe Human Microbiome Market by Countries
9.4.1 Europe Human Microbiome Revenue by Countries (2019-2030)
9.5 Germany
9.6 France
9.7 UK
9.8 Italy
9.9 Russia
9.10 Nordic
10 Latin America
10.1 Latin America Human Microbiome Revenue by Players
10.2 Latin America Human Microbiome Revenue by Types
10.3 Latin America Human Microbiome Revenue by Applications
10.4 Latin America Human Microbiome Market by Countries
10.4.1 Latin America Human Microbiome Revenue by Countries (2019-2030)
10.5 Brazil
10.6 Argentina
10.7 Mexico
11 Middle East & Africa
11.1 Middle East & Africa Human Microbiome Revenue by Players
11.2 Middle East & Africa Human Microbiome Revenue by Types
11.3 Middle East & Africa Human Microbiome Revenue by Applications
11.4 Middle East & Africa Human Microbiome Market by Countries
11.4.1 Middle East & Africa Human Microbiome Revenue by Countries (2019-2030)
11.5 Egypt
11.6 South Africa
11.7 Israel
11.8 Turkey
11.9 GCC Countries
12 Human Microbiome Industry Dynamic Analysis
12.1 Human Microbiome Market Trends Analysis
12.2 Human Microbiome Market Drivers Analysis
12.3 Human Microbiome Market Challenges Analysis
12.4 Human Microbiome Market Restraints Analysis
12.5 Human Microbiome Industry Mergers & Acquisitions
12.6 Human Microbiome Industry New Entrants and Expansion Plans
13 Research Findings and Conclusion

List of Tables and Figures

Figure Human Microbiome Picture
Table Product Definition of Human Microbiome
Table Global Human Microbiome Market Size by Type (2024 VS 2030)
Table Global Human Microbiome Market Size by Application (2024 VS 2030)
Table ENTEROME Profile
Table Product Overview
Table ENTEROME Human Microbiome Revenue, Gross and Gross Margin (2019-2024)
Figure ENTEROME Revenue and Growth Rate
Figure ENTEROME Revenue Market Share 2019-2024
Table Business Overview
Table Yakult Profile
Table Product Overview
Table Yakult Human Microbiome Revenue, Gross and Gross Margin (2019-2024)
Figure Yakult Revenue and Growth Rate
Figure Yakult Revenue Market Share 2019-2024
Table Business Overview
Table DuPont de Nemours Inc. Profile
Table Product Overview
Table DuPont de Nemours Inc. Human Microbiome Revenue, Gross and Gross Margin (2019-2024)
Figure DuPont de Nemours Inc. Revenue and Growth Rate
Figure DuPont de Nemours Inc. Revenue Market Share 2019-2024
Table Business Overview
Table ViThera Pharmaceuticals Inc. Profile
Table Product Overview
Table ViThera Pharmaceuticals Inc. Human Microbiome Revenue, Gross and Gross Margin (2019-2024)
Figure ViThera Pharmaceuticals Inc. Revenue and Growth Rate
Figure ViThera Pharmaceuticals Inc. Revenue Market Share 2019-2024
Table Business Overview
Table Second Genome Inc. Profile
Table Product Overview
Table Second Genome Inc. Human Microbiome Revenue, Gross and Gross Margin (2019-2024)
Figure Second Genome Inc. Revenue and Growth Rate
Figure Second Genome Inc. Revenue Market Share 2019-2024
Table Business Overview
Table Microbiome Therapeutics LLC Profile
Table Product Overview
Table Microbiome Therapeutics LLC Human Microbiome Revenue, Gross and Gross Margin (2019-2024)
Figure Microbiome Therapeutics LLC Revenue and Growth Rate
Figure Microbiome Therapeutics LLC Revenue Market Share 2019-2024
Table Business Overview
Table Vedanta Biosciences Inc. Profile
Table Product Overview
Table Vedanta Biosciences Inc. Human Microbiome Revenue, Gross and Gross Margin (2019-2024)
Figure Vedanta Biosciences Inc. Revenue and Growth Rate
Figure Vedanta Biosciences Inc. Revenue Market Share 2019-2024
Table Business Overview
Table Osel Inc. Profile
Table Product Overview
Table Osel Inc. Human Microbiome Revenue, Gross and Gross Margin (2019-2024)
Figure Osel Inc. Revenue and Growth Rate
Figure Osel Inc. Revenue Market Share 2019-2024
Table Business Overview
Table Merck Sharp & Dohme Corp Profile
Table Product Overview
Table Merck Sharp & Dohme Corp Human Microbiome Revenue, Gross and Gross Margin (2019-2024)
Figure Merck Sharp & Dohme Corp Revenue and Growth Rate
Figure Merck Sharp & Dohme Corp Revenue Market Share 2019-2024
Table Business Overview
Table Seres Therapeutics Profile
Table Product Overview
Table Seres Therapeutics Human Microbiome Revenue, Gross and Gross Margin (2019-2024)
Figure Seres Therapeutics Revenue and Growth Rate
Figure Seres Therapeutics Revenue Market Share 2019-2024
Table Business Overview
Table Global Human Microbiome Revenue and Market Size by Type (2019-2024)
Table Global Human Microbiome Revenue and Market Share by Type (2019-2024)
Table Global Human Microbiome Revenue Market Size Forecast by Type (2024-2030)
Table Global Human Microbiome Revenue Market Share Forecast by Type (2024-2030)
Table Global Human Microbiome Revenue Market Size by Application (2019-2024)
Table Global Human Microbiome Revenue Market Share by Application (2019-2024)
Table Global Human Microbiome Revenue Market Size by Application (2024-2030)
Table Global Human Microbiome Revenue Market Share by Application (2024-2030)
Figure Global Human Microbiome Revenue Market Size & Forecast (2019-2030)
Table Human Microbiome Market Size by Regions: 2019 VS 2024 VS 2030
Table Human Microbiome Historic Revenue Market Size by Regions (2019-2024)
Table Human Microbiome Historic Revenue Market Share by Regions (2019-2024)
Table Human Microbiome Forecasted Revenue Market Size by Regions (2024-2030)
Table Human Microbiome Forecasted Revenue Market Share by Regions (2024-2030)
Figure North America Human Microbiome Market Size & Forecast (2019-2030)
Figure Europe Human Microbiome Market Size & Forecast (2019-2030)
Figure China Human Microbiome Market Size & Forecast (2019-2030)
Figure Asia-Pacific (Excluding China) Human Microbiome Market Size & Forecast (2019-2030)
Figure Latin America Human Microbiome Market Size & Forecast (2019-2030)
Figure Middle East & Africa Human Microbiome Market Size & Forecast (2019-2030)
Table North America Human Microbiome Revenue Share by Players 2023
Table North America Human Microbiome Revenue by Types (2019-2024)
Table North America Human Microbiome Revenue Market Share by Types (2019-2024)
Table North America Human Microbiome Revenue by Applications (2019-2024)
Table North America Human Microbiome Revenue Market Share by Applications (2019-2024)
Table North America Human Microbiome Revenue by Countries (2019-2030)
Table North America Human Microbiome Revenue Market Share by Countries (2019-2030)
Figure United States Human Microbiome Revenue and Growth (2019-2030)
Figure Canada Human Microbiome Revenue and Growth (2019-2030)
Table China Human Microbiome Revenue Share by Players 2023
Table China Human Microbiome Revenue by Types (2019-2024)
Table China Human Microbiome Revenue Market Share by Types (2019-2024)
Table China Human Microbiome Revenue by Applications (2019-2024)
Table China Human Microbiome Revenue Market Share by Applications (2019-2024)
Figure China Human Microbiome Revenue and Growth (2019-2030)
Table Asia Pacific Human Microbiome Revenue Share by Players 2023
Table Asia Pacific Human Microbiome Revenue by Types (2019-2024)
Table Asia Pacific Human Microbiome Revenue Market Share by Types (2019-2024)
Table Asia Pacific Human Microbiome Revenue by Applications (2019-2024)
Table Asia Pacific Human Microbiome Revenue Market Share by Applications (2019-2024)
Table Asia-Pacific Human Microbiome Revenue by Countries (2019-2030)
Table Asia-Pacific Human Microbiome Revenue Market Share by Countries (2019-2030)
Figure Japan Human Microbiome Revenue and Growth (2019-2030)
Figure Korea Human Microbiome Revenue and Growth (2019-2030)
Figure Southeast Asia Human Microbiome Revenue and Growth (2019-2030)
Figure India Human Microbiome Revenue and Growth (2019-2030)
Figure Australia Human Microbiome Revenue and Growth (2019-2030)
Table Europe Human Microbiome Revenue Share by Players 2023
Table Europe Human Microbiome Revenue by Types (2019-2024)
Table Europe Human Microbiome Revenue Market Share by Types (2019-2024)
Table Europe Human Microbiome Revenue by Applications (2019-2024)
Table Europe Human Microbiome Revenue Market Share by Applications (2019-2024)
Table Europe Human Microbiome Revenue by Countries (2019-2030)
Table Europe Human Microbiome Revenue Market Share by Countries (2019-2030)
Figure Germany Human Microbiome Revenue and Growth (2019-2030)
Figure France Human Microbiome Revenue and Growth (2019-2030)
Figure UK Human Microbiome Revenue and Growth (2019-2030)
Figure Italy Human Microbiome Revenue and Growth (2019-2030)
Figure Russia Human Microbiome Revenue and Growth (2019-2030)
Figure Nordic Human Microbiome Revenue and Growth (2019-2030)
Table Latin America Human Microbiome Revenue Share by Players 2023
Table Latin America Human Microbiome Revenue by Types (2019-2024)
Table Latin America Human Microbiome Revenue Market Share by Types (2019-2024)
Table Latin America Human Microbiome Revenue by Applications (2019-2024)
Table Latin America Human Microbiome Revenue Market Share by Applications (2019-2024)
Table Latin America Human Microbiome Revenue by Countries (2019-2030)
Table Latin America Human Microbiome Revenue Market Share by Countries (2019-2030)
Figure Brazil Human Microbiome Revenue and Growth (2019-2030)
Figure Argentina Human Microbiome Revenue and Growth (2019-2030)
Figure Mexico Human Microbiome Revenue and Growth (2019-2030)
Table Latin America Human Microbiome Revenue Share by Players 2023
Table Middle East & Africa Human Microbiome Revenue by Types (2019-2024)
Table Middle East & Africa Human Microbiome Revenue Market Share by Types (2019-2024)
Table Middle East & Africa Human Microbiome Revenue by Applications (2019-2024)
Table Middle East & Africa Human Microbiome Revenue Market Share by Applications (2019-2024)
Table Middle East & Africa Human Microbiome Revenue by Countries (2019-2030)
Table Middle East & Africa Human Microbiome Revenue Market Share by Countries (2019-2030)
Figure Egypt Human Microbiome Revenue and Growth (2019-2030)
Figure South Africa Human Microbiome Revenue and Growth (2019-2030)
Figure Israel Human Microbiome Revenue and Growth (2019-2030)
Figure Turkey Human Microbiome Revenue and Growth (2019-2030)
Figure GCC Countries Human Microbiome Revenue and Growth (2019-2030)
Table Market Trends Analysis
Table Market Drivers Analysis
Table Market Challenges Analysis
Table Market Restraints Analysis
Table Market Mergers & Acquisitions
Table Market New Entrants and Expansion Plans